Sanofi (SNY) Assets (2009 - 2026)
Sanofi (SNY) posted Assets of $149.9 billion for Q1 2026, up 1.54% sequentially from $147.6 billion in Q4 2025, and up 8.04% YoY from $138.7 billion in Q1 2025.
Sanofi (SNY) Assets (2009 - 2026) Analysis & Trends
Sanofi (SNY) has 18 years of Assets data on file, last reported at $149.9 billion in Q1 2026.
- Quarterly Assets rose 8.04% year-over-year to $149.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149.9 billion (up 8.04% YoY) and the FY2025 annual result came in at $147.6 billion, up 4.02% from the prior year.
- Assets rose to $149.9 billion in Q1 2026 per SNY's latest filing, from $147.6 billion in the prior quarter.
- The five-year high for Assets was $151.7 billion in Q3 2025, with the low at $129.3 billion in Q4 2022.
- Average Assets over 5 years is $140.3 billion, with a median of $139.7 billion recorded in 2024.
- Year-over-year, Assets dropped 6.01% in 2022 and gained 8.04% in 2026.
- Sanofi's Assets stood at $129.3 billion in 2022, then rose by 5.24% to $136.1 billion in 2023, then rose by 4.29% to $141.9 billion in 2024, then gained by 4.02% to $147.6 billion in 2025, then advanced by 1.54% to $149.9 billion in 2026.
- Business Quant data shows SNY's Assets at $149.9 billion in Q1 2026, $147.6 billion in Q4 2025, and $151.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 116.58 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 200.89 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 136.46 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 114.02 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 128.69 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 92.50 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 56.28 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 208.00 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Sanofi | - | - | 9.49 Bn | 149.88 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149.88 Bn |
| Dec 31, 2025 | 147.61 Bn |
| Sep 30, 2025 | 151.74 Bn |
| Jun 30, 2025 | 141.45 Bn |
| Mar 31, 2025 | 138.74 Bn |
| Dec 31, 2024 | 141.91 Bn |
| Jun 30, 2024 | 139.73 Bn |
| Dec 31, 2023 | 136.07 Bn |
| Jun 30, 2023 | 136.50 Bn |
| Dec 31, 2022 | 129.29 Bn |
| Jun 30, 2022 | 130.00 Bn |
| Dec 31, 2021 | 137.55 Bn |
| Jun 30, 2021 | 135.26 Bn |
| Dec 31, 2020 | 1.91 Bn |
| Jun 30, 2020 | 127.57 Bn |
| Dec 31, 2019 | 1.75 Bn |
| Jun 30, 2019 | 124.21 Bn |
| Dec 31, 2018 | 127.16 Bn |
| Sep 30, 2018 | 1.85 Bn |
| Jun 30, 2018 | 134.59 Bn |